Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are some of the confirmed speakers for the 2021 Series.

Alekhya Pochiraju

Product Development Manager, Global Operations

Genentech

Anna Kostikova

Director of Translational Data Science

Novartis

Axel Ducret

Project leader Immunosafety and Protein Biomarkers

Roche

Ben Sidders

Associate Director, Oncology Bioinformatics

AstraZeneca

Bernando Lemos

Associate Professor of Environmental Epigenetics

Harvard University

Caoimhe Vallely-Gilroy

Global Head of Data Analytics and Strategy for Healthcare

Merck KGaA

Catherine Panabieres

Director, Laboratory of Rare Human Circulating Cells, Pathology and Onco-Biology Department

Universite de Montpellier

Christie Fanton

Senior Director, Translational Medicine

Nektar Therapeutics

Christina Gerwinner

Translational Biologist

Astex Pharma

Dana Connors

Senior Project Manager

FNIH

Daniel Stetson

Associate Principal Scientist

AstraZeneca

Darrell Borger

Associate Director, Translational Oncology

Takeda

Don White

Programme Manager, Stratified Medicine

Cancer Research UK

Ed Schuuring

Full Professor in Molecular Oncological Pathology and Senior Clinical Scientist in Molecular Pathology

University Medical Center Groningen

Eduardo Bruno Martins

Vice President, Clinical Development - Liver Disease

Allergan

Eleftheria Pissadaki

Manager, Systems Neuroscience

Biogen

Elizabeth Somers

Diagnostic Pathway Lead

Eisai

Emanuela Oldoni

Scientific Project Manager

EATRIS

Evi Lianidou

Professor of Analytical Chemistry

University of Athens

Hubert Aviolat

Senior Scientist

AbbVie

Ivor Royston

President and Chief Executive Officer

Viracta

Jane Wilkinson

Senior Director

Broad Institute

John Zibert

Chief Executive Officer

LEO Pharma Innovation

Ken Raj

Scientific Group Leader

Public Health England

Lourdes Barrera

Global Senior Director Precision Medicine

Novartis

Lynne Cox

Professor

Oxford University

Maciej Cabanski

Biomarker Expert

Novartis

Mario Richter

Translational Science Area Lead DMPK-BA

AbbVie

Megan Fealey

NovaSeq Implementation Lead & Lead Genetic Technologist

NHS

Michael Baratta

Scientific Director, Clinical Biomarker Development Innovation

Takeda

Michael Roehrl

Director, Precision Pathology Biobanking Center

Memorial Sloane Kettering Cancer Center

Michael Rotte

Global Head Biomarker Development

Novartis

Mike Makrigiorgos

Director, Cancer Genomics

Harvard

Niharika Duggal

Lecturer in Immunity and Ageing

University of Birmingham

Nir Barzilai

Director of the Institute for Ageing Research

Albert Enstein College

Ranjan Batra

Vice President, R&D

Locana Bio

Richard Sainson

Senior Director, Translational Immuno-Oncology

Kymab

Risha Kohli

Director, Precision Oncology

Merck & Co

Romina Durigon

Chief Operations Officer

Shift Bioscience

Sarah Paul

Senior Scientific Manager & Biomarker Lead

Genentech

Stephen Blakemore

Vice President, Translational Oncology & Diagnostics

Bicycle Therapeutics

Talisia Quallo

Programme Manager, Early Detection

Cancer Research UK

Tarek Leil

Head, Quantitative Clinical Pharmacology

Bristol-Myers Squibb

Thomas Condamine

Senior Director, Translational Sciences

Carisma Therapeutics

Thomas Misko

Director

AbbVie

Valentin Hamy

Data Analytics Leader - Digital Biomarkers

GlaxoSmithKline

Vilma Decman

Director, Head of the Cellular Biomarkers Group, Bioanalysis, Immunogenicity & Biomarkers

GlaxoSmithKline

Zisis Kozlakidis

Head, Laboratory Services and Biobanking

International Agency for Research on Cancer

: Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are some of the confirmed speakers for the 2021 Series.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.